LYMEINFORMATION TESTOSTERONE EFFECTS TOP DOCTOR DHEA FREE THYROID
main page books and articles schaller health creed facebook testimonies search
menu main page what's new second opinion new patient meet doctor schaller location, travel

Frequent inaccuracies in testosterone testing lead to call for standardization

UNTREATED LYME DISEASE MAY IMPACT TESTOSTERONE, DHEA, FREE THYROID, AND HASHIMOTO'S THYRIODITIS SINCE INCREASED INFLAMMATION APPEARS TO INCREASE AUTOIMMUNITY AND ALLERGIES OVER TIME.

MOST NATURAL HORMONES LIKELY REQUIRED FOR OPTIMAL HEALTH FALL AS EARLY AS THE 30'S, AND FALL SIGNIFICANTLY IN THE 40'S AND 50'S. IF YOU ADD THE IMPACT OF UNTREATED LYME DISEASE WE FEEL IT ADDS TO THE DECREASE IN 85% OR MORE. WE ARE NOT SURE IF BABESIA AND BARTONELLA ALSO ADD TO THIS DECREASE.

ONE PROBLEM IS FEW PHYSICIANS CHECK THE IDEAL LABS. FOR EXAMPLE, FREE TESTOSTERONE IS THE USABLE TESTOSTERONE, NOT TOTAL TESTOSTERONE. AND A BINDING PROTEIN CAN MAKE THIS "TOTAL" LESS ABLE TO BE FREE TO HELP YOU.

NOW WE LEARN, THAT NOT ONLY ARE REFERENCE RANGES BEING DROPPED AS MORE ELDERLY ARE CONSIDERED TO HAVE "NORMAL" HORMONE RESULTS, BUT THE LABS ARE INACCURATE. THIS IS NO SURPRISE BECAUSE TOP LABS HAVE A NUMBER OF LABS THAT ARE FLAWED. WHEN YOU OFFER 1,000 LAB TESTS, IT IS IMPOSSIBLE TO OFFER THE BEST QUALITY FOR EACH.

SEE BELOW TERSE QUOTES:

In partnership with the CDC, national leaders in scientific and medical communities issue a call to action to ensure accurate and reliable testosterone tests.

Chevy Chase, MD—The use of testosterone assays for patient care and research is on the rise as new research links testosterone to a variety of diseases and conditions. Although the assays are heavily used, discrepancies and inaccuracies in measurements resulting from the various assays are widespread. Seeking to address this critical health issue, a multidisciplinary group of experts convened by The Endocrine Society and the US Centers for Disease Control and Prevention just issued recommendations for improving and standardizing testosterone testing in a consensus statement to be published in the October 2010 issue of The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

Testosterone assays are tests that measure testosterone levels which, in turn, are used to diagnose and treat patients with a number of disorders. These disorders may include: testicular or pituitary diseases in men potentially leading to erectile dysfunction and decreased sexual drive; polycystic ovarian syndrome which may cause menstrual disturbances and infertility in women; and early or late pubertal development in children....

"The recommendations in this consensus statement emphasize the need for the research, medical and industry communities to each play their part in improving testosterone assays," said Rosner. "...High quality testosterone testing will not only provide for better patient care outcomes...."

The consensus statement has been endorsed by the following organizations:

  • American Association for Clinical Chemistry
  • American Association of Clinical Endocrinologists
  • Androgen Excess/PCOS Society
  • American Society for Bone and Mineral Research
  • American Society for Reproductive Medicine
  • American Urological Association
  • Association of Public Health Laboratories
  • The Endocrine Society
  • Laboratory Corporation of America
  • North American Menopause Society
  • Pediatric Endocrine Society (formerly known as Lawson Wilkins Pediatric
  • Endocrine Society)

The statement, "Toward Excellence in Testosterone Testing; A Consensus Statement," will appear in the October 2010 issue of JCEM.

SOURCE OF QUOTES: www.eurekalert.org/pub_releases/2010-10/tes-fii100510


Bank Towers, Tamiami Trail, Naples, FL
disclaimer privacy